Inventiva S.A. (IVA) - Latest Market Data

Price & Market Data

Price: $5.07

Daily Change: -$0.14 / 2.76%

Daily Range: $5.05 - $5.31

Market Cap: $1,059,366,016

Daily Volume: 185,067

Performance Metrics

1 Week: -9.19%

1 Month: -3.56%

3 Months: -21.04%

6 Months: 28.18%

1 Year: 63.17%

YTD: 10.54%

About Inventiva S.A. (IVA)

A concise financial summary for Inventiva S.A. (IVA). Priced at 5.07, it shows a daily movement of -$0.14 / 2.76%. Market cap: 1,059,366,016. Performance over 1-week and 1-year are key takeaways.

Company Details

Employees: 77

Sector: Health technology

Industry: Biotechnology

Country: France

Details

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.

Selected stocks

Empire Petroleum Corporation (EP)

AN2 Therapeutics, Inc. (ANTX)

Vivani Medical, Inc. (VANI)

Delixy Holdings Limited (DLXY)